Published in
Impact Journals, Oncotarget, 3(9), p. 3605-3618, 2017
DOI: 10.18632/oncotarget.23188
Links
Tools
Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option
Journal article published in 2017 by
Peter Dietrich,
Kim Freese,
Abdo Mahli 
,
Wolfgang Erwin Thasler,
Claus Hellerbrand,
Anja Katrin Bosserhoff
,
Wolfgang Erwin Thasler,
Claus Hellerbrand,
Anja Katrin Bosserhoff
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 